Fabrice Barlesi, MD
Gustave Roussy, Cancer Campus, Grand Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fabrice Barlesi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05865730 · A Study of Oncobax®-AK in Patients With Advanced Solid TumorsEverImmune · unknown · Carcinoma, Renal Cell, Carcinoma, Non-Small-Cell Lung · principal investigator
- Ph3NCT05221840 · A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerAstraZeneca · active not recruiting · Non-Small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.